The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Motion Sickness Treatment Market Research Report 2024
Synopsis
Motion sickness is a condition experienced by patient caused due to difference between the visually perceived motion and vestibular system’s senses of movement. Motion sickness is characterized by a set of symptoms such as nausea, fatigue, and dizziness.
The global Motion Sickness Treatment market was valued at US$ 1316.8 million in 2023 and is anticipated to reach US$ 2198.7 million by 2030, witnessing a CAGR of 7.6% during the forecast period 2024-2030.
Motion sickness is a common condition experienced by around 50% to 60% of the general global population. It is more common in children and elderly. Various prescription and over the counter (OTC) drugs and products are available for treat motion sickness.
This report aims to provide a comprehensive presentation of the global market for Motion Sickness Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Motion Sickness Treatment.
Report Scope
The Motion Sickness Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Motion Sickness Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Motion Sickness Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Perrigo Company
Prestige Brands
WellSpring Pharmaceutical Corporation
Caleb Pharmaceuticals
Myungmoon Pharm
Baxter International
Reliefband Technologies
Segment by Type
Anticholinergic
Antihistamines
Others
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Motion Sickness Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Motion sickness is a condition experienced by patient caused due to difference between the visually perceived motion and vestibular system’s senses of movement. Motion sickness is characterized by a set of symptoms such as nausea, fatigue, and dizziness.
The global Motion Sickness Treatment market was valued at US$ 1316.8 million in 2023 and is anticipated to reach US$ 2198.7 million by 2030, witnessing a CAGR of 7.6% during the forecast period 2024-2030.
Motion sickness is a common condition experienced by around 50% to 60% of the general global population. It is more common in children and elderly. Various prescription and over the counter (OTC) drugs and products are available for treat motion sickness.
This report aims to provide a comprehensive presentation of the global market for Motion Sickness Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Motion Sickness Treatment.
Report Scope
The Motion Sickness Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Motion Sickness Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Motion Sickness Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Perrigo Company
Prestige Brands
WellSpring Pharmaceutical Corporation
Caleb Pharmaceuticals
Myungmoon Pharm
Baxter International
Reliefband Technologies
Segment by Type
Anticholinergic
Antihistamines
Others
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Motion Sickness Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Motion Sickness Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Anticholinergic
1.2.3 Antihistamines
1.2.4 Others
1.3 Market by Application
1.3.1 Global Motion Sickness Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Motion Sickness Treatment Market Perspective (2019-2030)
2.2 Motion Sickness Treatment Growth Trends by Region
2.2.1 Global Motion Sickness Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Motion Sickness Treatment Historic Market Size by Region (2019-2024)
2.2.3 Motion Sickness Treatment Forecasted Market Size by Region (2025-2030)
2.3 Motion Sickness Treatment Market Dynamics
2.3.1 Motion Sickness Treatment Industry Trends
2.3.2 Motion Sickness Treatment Market Drivers
2.3.3 Motion Sickness Treatment Market Challenges
2.3.4 Motion Sickness Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Motion Sickness Treatment Players by Revenue
3.1.1 Global Top Motion Sickness Treatment Players by Revenue (2019-2024)
3.1.2 Global Motion Sickness Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Motion Sickness Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Motion Sickness Treatment Revenue
3.4 Global Motion Sickness Treatment Market Concentration Ratio
3.4.1 Global Motion Sickness Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Motion Sickness Treatment Revenue in 2023
3.5 Motion Sickness Treatment Key Players Head office and Area Served
3.6 Key Players Motion Sickness Treatment Product Solution and Service
3.7 Date of Enter into Motion Sickness Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Motion Sickness Treatment Breakdown Data by Type
4.1 Global Motion Sickness Treatment Historic Market Size by Type (2019-2024)
4.2 Global Motion Sickness Treatment Forecasted Market Size by Type (2025-2030)
5 Motion Sickness Treatment Breakdown Data by Application
5.1 Global Motion Sickness Treatment Historic Market Size by Application (2019-2024)
5.2 Global Motion Sickness Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Motion Sickness Treatment Market Size (2019-2030)
6.2 North America Motion Sickness Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Motion Sickness Treatment Market Size by Country (2019-2024)
6.4 North America Motion Sickness Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Motion Sickness Treatment Market Size (2019-2030)
7.2 Europe Motion Sickness Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Motion Sickness Treatment Market Size by Country (2019-2024)
7.4 Europe Motion Sickness Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Motion Sickness Treatment Market Size (2019-2030)
8.2 Asia-Pacific Motion Sickness Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Motion Sickness Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Motion Sickness Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Motion Sickness Treatment Market Size (2019-2030)
9.2 Latin America Motion Sickness Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Motion Sickness Treatment Market Size by Country (2019-2024)
9.4 Latin America Motion Sickness Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Motion Sickness Treatment Market Size (2019-2030)
10.2 Middle East & Africa Motion Sickness Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Motion Sickness Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Motion Sickness Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Detail
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Motion Sickness Treatment Introduction
11.1.4 GlaxoSmithKline Revenue in Motion Sickness Treatment Business (2019-2024)
11.1.5 GlaxoSmithKline Recent Development
11.2 Perrigo Company
11.2.1 Perrigo Company Company Detail
11.2.2 Perrigo Company Business Overview
11.2.3 Perrigo Company Motion Sickness Treatment Introduction
11.2.4 Perrigo Company Revenue in Motion Sickness Treatment Business (2019-2024)
11.2.5 Perrigo Company Recent Development
11.3 Prestige Brands
11.3.1 Prestige Brands Company Detail
11.3.2 Prestige Brands Business Overview
11.3.3 Prestige Brands Motion Sickness Treatment Introduction
11.3.4 Prestige Brands Revenue in Motion Sickness Treatment Business (2019-2024)
11.3.5 Prestige Brands Recent Development
11.4 WellSpring Pharmaceutical Corporation
11.4.1 WellSpring Pharmaceutical Corporation Company Detail
11.4.2 WellSpring Pharmaceutical Corporation Business Overview
11.4.3 WellSpring Pharmaceutical Corporation Motion Sickness Treatment Introduction
11.4.4 WellSpring Pharmaceutical Corporation Revenue in Motion Sickness Treatment Business (2019-2024)
11.4.5 WellSpring Pharmaceutical Corporation Recent Development
11.5 Caleb Pharmaceuticals
11.5.1 Caleb Pharmaceuticals Company Detail
11.5.2 Caleb Pharmaceuticals Business Overview
11.5.3 Caleb Pharmaceuticals Motion Sickness Treatment Introduction
11.5.4 Caleb Pharmaceuticals Revenue in Motion Sickness Treatment Business (2019-2024)
11.5.5 Caleb Pharmaceuticals Recent Development
11.6 Myungmoon Pharm
11.6.1 Myungmoon Pharm Company Detail
11.6.2 Myungmoon Pharm Business Overview
11.6.3 Myungmoon Pharm Motion Sickness Treatment Introduction
11.6.4 Myungmoon Pharm Revenue in Motion Sickness Treatment Business (2019-2024)
11.6.5 Myungmoon Pharm Recent Development
11.7 Baxter International
11.7.1 Baxter International Company Detail
11.7.2 Baxter International Business Overview
11.7.3 Baxter International Motion Sickness Treatment Introduction
11.7.4 Baxter International Revenue in Motion Sickness Treatment Business (2019-2024)
11.7.5 Baxter International Recent Development
11.8 Reliefband Technologies
11.8.1 Reliefband Technologies Company Detail
11.8.2 Reliefband Technologies Business Overview
11.8.3 Reliefband Technologies Motion Sickness Treatment Introduction
11.8.4 Reliefband Technologies Revenue in Motion Sickness Treatment Business (2019-2024)
11.8.5 Reliefband Technologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
